UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Browse by UCL Departments and Centres

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Author | Type
Jump to: A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | Y | Z
Number of items: 338.

A

Abbott, WGH; Rigópoulou, E; Haigh, P; Cooksley, H; Mullerova, I; Novelli, M; Winstanley, A; (2004) Single nucleotide polymorphisms in the interferon-γ and interleukin-10 genes do not influence chronic hepatitis C severity or T-cell reactivity to hepatitis C virus. Liver International , 24 (2) pp. 90-97.

Abdalla, SI; Lao-Sirieix, P; Novelli, MR; Lovat, LB; Sanderson, IR; Fitzgerald, RC; (2004) Gastrin-induced cyclooxygenase-2 expression in Barrett's carcinogenes. CLIN CANCER RES , 10 (14) 4784 - 4792.

Adib, TR; Henderson, S; Perrett, C; Hewitt, D; Bourmpoulia, D; Ledermann, J; Boshoff, C; (2004) Predicting biomarkers for ovarian cancer using gene-expression microarrays. British Journal of Cancer , 90 (3) pp. 686-692. 10.1038/sj.bjc.6601603.

Adib, TR; Henderson, S; Perrett, C; Hewitt, D; Bourmpoulia, D; Ledermann, J; Boshoff, C; (2004) Predicting biomarkers for ovarian cancer using gene-expression microarrays. BRIT J CANCER , 90 (3) 686 - 692. 10.1038/sj.bjc.6601603.

Ahmed, F; Ings, SJ; Pizzey, AR; Blundell, MP; Thrasher, AJ; T Ye, H; Fahey, A; (2004) Impaired bone marrow homing of cytokine-activated CD34(+) cells in the NOD/SCID model. BLOOD , 103 (6) 2079 - 2087. 10.1182/blood-2003-06-1770.

Ahmed, F; Ings, SJ; Pizzey, AR; Blundell, MP; Thrasher, AJ; Ye, HT; Fahey, A; (2004) Impaired bone marrow homing of cytokine-activated CD34+ cells in the NOD/SCID model. Blood , 103 (6) pp. 2079-2087. 10.1182/blood-2003-06-1770. Green open access
file

Akbar, AN; Beverley, PCL; Salmon, M; (2004) Opinion - Will telomere erosion lead to a loss of T-cell memory? NAT REV IMMUNOL , 4 (9) 737 - 743. 10.1038/nri1440.

Ali, K; Bilancio, A; Thomas, M; Pearce, W; Gilfillan, AM; Tkaczyk, C; Kuehn, N; (2004) Essential role for the p110 delta phosphoinositide 3-kinase in the allergic response. NATURE , 431 (7011) pp. 1007-1011. 10.1038/nature02991.

Ali, K; Bilancio, A; Thomas, M; Pearce, W; Gilfillan, AM; Tkaczyk, C; Kuehn, N; (2004) Essential role for the p110δ phosphoinositide 3-kinase in the allergic response. Nature , 431 (7011) pp. 1007-1011. 10.1038/nature02991.

Alley, MC; Hollingshead, MG; Pacula-Cox, CM; Wand, WR; Hartley, JA; Howard, PW; Gregson, SJ; (2004) SJG-136 (NSC 694501), a novel rationally designed DNA minor groove interstrand cross-linking agent with potent and broad spectrum antitumor activity. Part 2: Efficacy evaluations. CANCER RES , 64 (18) 6700 - 6706.

Anderson, LJ; Westwood, MA; Holden, S; Davis, B; Prescott, E; Wonke, B; Porter, JB; (2004) Myocardial iron clearance during reversal of siderotic cardiomyopathy with intravenous desferrioxamine: a prospective study using T2*cardiovascular magnetic resonance. BRIT J HAEMATOL , 127 (3) 348 - 355. 10.1111/j.1365-2141.2004.05202.x.

André, T; Boni, C; Mounedji-Boudiaf, L; Navarro, M; Tabernero, J; Hickish, T; Topham, C; (2004) Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med , 350 (23) pp. 2343-2351. 10.1056/NEJMoa032709. Green open access
file

Ansari, J; Nagabhushan, N; Syed, R; Bomanji, J; Bacon, CM; Lee, SM; (2004) Small cell lung cancer associated with anti-Hu paraneoplastic sensory neuropathy and peripheral nerve microvasculitis: Case report and literature review. CLINICAL ONCOLOGY , 16 (1) pp. 71-76. 10.1016/j.clon.2003.09.008.

Ansell, SM; Arendt, BK; Grote, DM; Jelinek, DF; Novak, AJ; Wellik, LE; Remstein, ED; (2004) Inhibition of survivin expression suppresses the growth of aggressive non-Hodgkin's lymphoma. LEUKEMIA , 18 (3) pp. 616-623. 10.1038/sj.leu.2403281.

Ansell, SM; Arendt, BK; Grote, DM; Jelinek, DF; Novak, AJ; Wellik, LE; Remstein, ED; (2004) Inihibitor of survivin expression suppresses the growth of aggressive non-Hodgkin's lymphoma. Leukemia , 18 (3) pp. 616-623. 10.1038/sj.leu.2403281.

Attygalle, AD; Diss, TC; Munson, P; Isaacson, PG; Du, MQ; Dogan, A; (2004) CD10 expression in extranodal dissemination of Angioimmunoblastic T-cell lymphoma. AMERICAN JOURNAL OF SURGICAL PATHOLOGY , 28 (1) pp. 54-61. 10.1097/00000478-200401000-00005.

Attygalle, AD; Liu, HX; Shirali, S; Diss, TC; Loddenkemper, C; Stein, H; Dogan, A; (2004) Atypical marginal zone hyperplasia of mucosa-associated lymphoid tissue: a reactive condition of childhood showing immunoglobulin lambda light-chain restriction. BLOOD , 104 (10) pp. 3343-3348. 10.1182/blood-2004-01-0385. Green open access
file

Avivi, I; Chakrabarti, S; Kottaridis, P; Kyriaku, C; Dogan, A; Milligan, DW; Linch, D; (2004) Neurological complications following alemtuzumab-based reduced-intensity allogeneic transplantation. Bone Marrow Transplant , 34 (2) pp. 137-142. 10.1038/sj.bmt.1704538.

Avivi, I; Chakrabarti, S; Milligan, DW; Waldmann, H; Hale, G; Osman, H; Ward, KN; (2004) Incidence and outcome of Adenovirus disease in transplant recipients after reduced-intensity conditioning with alemtuzumab. BIOL BLOOD MARROW TR , 10 (3) 186 - 194. 10.1016/j.bbmt.2003.11.001.

Avivi, I; Chakrabarti, S; Milligan, DW; Waldmann, H; Hale, G; Osman, H; Ward, KN; (2004) Incidence and outcome of adenovirus disease in transplant recipients after reduced-intensity conditioning with alemtuzumab. Biol Blood Marrow Transplant , 10 (3) pp. 186-194. 10.1016/j.bbmt.2003.11.001.

B

Bacon, CM; Miller, RF; Noursadeghi, M; McNamara, C; Du, MQ; Dogan, A; (2004) Pathology of bone marrow in human herpes virus-8 (HHV8)-associated multicentric Castleman disease. BRIT J HAEMATOL , 127 (5) 585 - 591. 10.1111/j.1365-2141.2004.05230.x.

Bagshawe, KD; Sharma, SK; Begent, RHJ; (2004) Antibody-directed enzyme prodrug therapy (ADEPT) for cancer. EXPERT OPIN BIOL TH , 4 (11) 1777 - 1789. 10.1517/14712598.4.11.1777.

Baraldi, PG; Beria, I; Cozzi, P; Geroni, C; Espinosa, A; Gallo, MA; Entrena, A; (2004) Cinnamoyl nitrogen mustard derivatives of pyrazole analogues of tallimustine modified at the amidino moiety: design, synthesis, molecular modeling and antitumor activity studies. BIOORGAN MED CHEM , 12 (14) 3911 - 3921. 10.1016/j.bmc.2004.04.045.

Barber, L; Whitelegg, A; on, M; igal, J; Banner, N; olas, R; (2004) Detection of vimentin-specific autoreactive CD8+ T cells in cardiac transplant patients. TRANSPLANTATION , 77 (10) pp. 1604-1609.

Bates, AW; (2004) The sooterkin doctor: the London career of John Maubray, MD (1700-1732), "andro-boethogynist". J Med Biogr , 12 (3) pp. 147-153.

Beck, S; (2004) Dr Nat Bumstead: Pioneer researcher in mapping the chicken genome. DNA SEQUENCE , 15 (3) 165 - 166. 10.1080/10425170410001716073.

Bell, CG; Benzinou, M; Siddiq, A; Lecoeur, C; Dina, C; Lemainque, A; Clément, K; (2004) Genome-wide linkage analysis for severe obesity in french caucasians finds significant susceptibility locus on chromosome 19q. Diabetes , 53 (7) pp. 1857-1865.

Bellodi, C; Kindle, K; Bernassola, F; Dinsdale, D; Melino, G; Cossarizza, A; Heery, D; (2004) Mutant PML proteins form novel cytoplasmic bodies. In: BLOOD. (pp. 952A - 952A). AMER SOC HEMATOLOGY

Benchaouir, R; Rameau, P; Decraene, C; Dreyfus, P; Israeli, D; Piétu, G; Danos, O; (2004) Evidence for a resident subset of cells with SP phenotype in the C2C12 myogenic line: a tool to explore muscle stem cell biology. Exp Cell Res , 294 (1) pp. 254-268. 10.1016/j.yexcr.2003.11.005.

Bernassola, F; Salomoni, P; Oberst, A; Di Como, CJ; Pagano, M; Melino, G; Pandolfi, PP; (2004) Ubiquitin-dependent degradation of p73 is inhibited by PML. J EXP MED , 199 (11) 1545 - 1557. 10.1084/jem.20031943.

Bhattacharjya, S; Bhattacharjya, T; Quaglia, A; Dhillon, AP; Burroughs, AK; Patch, DW; Tibballs, JM; (2004) Liver transplantation in cirrhotic patients with small hepatocellular carcinoma: An analysis of pre-operative imaging, explant histology and prognostic histologic indicators. DIGEST SURG , 21 (2) 152 - 159. 10.1159/000078741.

Birnie, A; Gazzard, BG; Bacon, C; Dogan, A; Shaw, PJ; Miller, RF; (2004) Fever in the recently returned HIV infected traveller. SEX TRANSM INFECT , 80 (2) 86 - 90. 10.1136/sti.2003.008755.

Blundell, M; Ancliff, P; Cory, G; Jones, G; de Botton, S; Vainchanker, W; Thrasher, AJ; (2004) Unregulated activation of the actin cytoskeleton through WASp promoters cell death and genomic instability. Presented at: UNSPECIFIED.

Bourboulia, D; Aldam, D; Lagos, D; Allen, E; Williams, I; Cornforth, D; Copas, A; (2004) Short- and long-term effects of highly active antiretroviral therapy on Kaposi sarcoma-associated herpesvirus immune responses and viraemia. AIDS , 18 (3) pp. 485-493. 10.1097/00002030-200402200-00015.

Bourboulia, D; Aldam, D; Lagos, D; Allen, E; Williams, I; Cornforth, D; Copas, A; (2004) Short- and long-term effects of highly active antiretroviral therapy on Kaposi sarcoma-associated herpesvirus immune responses and viraemia. AIDS , 18 (3) 485 - 493. 10.1097/01.aids.0000111409.02002.b8.

Bourboulia, D.; (2004) Humoral and cellular immune responses against Kaposi's sarcoma-associated herpesvirus (KSHV). Doctoral thesis, University of London. Green open access
file

Bower, M; Powles, T; Newsom-Davis, T; Thirlwell, C; Stebbing, J; Mandalia, S; Nelson, M; (2004) HIV-associated anal cancer - Has highly active antiretroviral therapy reduced the incidence or improved the outcome? JAIDS-J ACQ IMM DEF , 37 (5) 1563 - 1565.

Boxall, EH; Sira, J; Standish, RA; Davies, P; Sleight, E; Dhillon, AP; Scheuer, PJ; (2004) Natural history of hepatitis B in perinatally infected carriers. ARCH DIS CHILD , 89 (5) F456 - F460. 10.1136/adc.2002.009837.

Brealey, D; Karyampudi, S; Jacques, TS; Novelli, M; Stidwill, R; Taylor, V; Smolenski, RT; (2004) Mitochondrial dysfunction in a long-term rodent model of sepsis and organ failure. AM J PHYSIOL-REG I , 286 (3) R491 - R497. 10.1152/ajpregu.00432.2003.

Bruno, L; Hoffmann, R; McBlane, F; Brown, J; Gupta, R; Joshi, C; Pearson, S; (2004) Molecular signatures of self-renewal, differentiation, and lineage choice in multipotential hemopoietic progenitor cells in vitro. MOLECULAR AND CELLULAR BIOLOGY , 24 (2) pp. 741-756. 10.1128/MCB.24.2.741-756.2004.

Burns, S; Hardy, SJ; Buddle, J; Yong, KL; Jones, GE; Thrasher, AJ; (2004) Maturation of DC is associated with changes in motile characteristics and adherence. CELL MOTIL CYTOSKEL , 57 (2) 118 - 132. 10.1002/cm.10163.

Burroughs, A; Hochhauser, D; Meyer, T; (2004) Systemic treatment and liver transplantation for hepatocellular carcinoma: two ends of the therapeutic spectrum. Lancet Oncol , 5 (7) pp. 409-418. 10.1016/S1470-2045(04)01508-6.

Burton, C; Ell, P; Linch, D; (2004) The role of PET imaging in lymphoma. BRITISH JOURNAL OF HAEMATOLOGY , 126 (6) pp. 772-784. 10.1111/j.1365-2141.2004.05069.x.

C

Calabrese, CR; Almassy, R; Barton, S; Batey, MA; Calvert, AH; Canan-Koch, S; Durkacz, BW; (2004) Anticancer chemosensitization and radiosensitization by the novel poly(ADP-ribose) polymerase-1 inhibitor AG14361. J NATL CANCER I , 96 (1) 56 - 67. 10.1093/jnci/djh005.

Calvert, AH; (2004) Biochemical pharmacology of pemetrexed. Oncology (Williston Park) , 18 (13 Suppl) pp. 13-17.

Camilleri, RS; Peebles, D; Portmann, C; Everington, T; Cohen, H; (2004) -455G/A beta-fibrinogen gene polymorphism, factor V Leiden, prothrombin G20210A mutation and MTHFR C677T, and placental vascular complications. BLOOD COAGUL FIBRIN , 15 (2) 139 - 147. 10.1097/01.mbc.0000114378.15192.1a.

Camilleri, RS; Peebles, D; Portmann, C; Everington, T; Cohen, H; (2004) -455G/A β-fibrinogen gene polymorphism, factor V Leiden, prothrombin G20210A mutation and MTHFR C677T, and placental vascular complications. Blood Coagulation and Fibrinolysis , 15 (2) pp. 139-147. 10.1097/00001721-200403000-00005.

Campbell, M; Allen, WE; Sawyer, C; Vanhaesebroeck, B; Trimble, ER; (2004) Glucose-potentiated chemotaxis in human vascular smooth muscle is dependent on cross-talk between the PI3K and MAPK signaling pathways. Circ Res , 95 (4) pp. 380-388. 10.1161/01.RES.0000138019.82184.5d.

Castillon, N; Avril-Delplanque, A; Coraux, C; Delenda, C; Péault, B; Danos, O; Puchelle, E; (2004) Regeneration of a well-differentiated human airway surface epithelium by spheroid and lentivirus vector-transduced airway cells. J Gene Med , 6 (8) pp. 846-856. 10.1002/jgm.570.

Cavenagh, JD; Popat, R; Curry, N; Stec, J; Morris, TC; Drake, M; Agrawal, S; (2004) PAD combination therapy (PS-341/bortezomib, adriamycin and dexamethasone) for previously untreated patients with multiple myeloma. In: (Proceedings) 46th Annual Meeting of the American-Society-of-Hematology. (pp. 413A-413A). AMER SOC HEMATOLOGY

Chen, JH; Stoeber, K; Kingsbury, S; Ozanne, SE; Williams, GH; Hales, CN; (2004) Loss of proliferative capacity and induction of senescence in oxidatively stressed human fibroblasts. J BIOL CHEM , 279 (47) 49439 - 49446. 10.1074/jbc.M409153200. Gold open access

Chester, JD; Hall, GD; Forster, M; Protheroe, AS; (2004) Systemic chemotherapy for patients with bladder cancer--current controversies and future directions. Cancer Treat Rev , 30 (4) pp. 343-358. 10.1016/j.ctrv.2003.12.005.

Chester, K; Pedley, B; Tolner, B; Violet, J; Mayer, A; Sharma, S; Boxer, G; (2004) Engineering antibodies for clinical applications in cancer. Tumor Biology , 25 (1-2) pp. 91-98.

Chester, K; Pedley, B; Tolner, B; Violet, J; Mayer, A; Sharma, S; Boxer, G; (2004) Engineering antibodies for clinical applications in cancer. TUMOR BIOL , 25 (1-2) 91 - 98. 10.1159/000077727.

Chew, SK; Akdemir, F; Chen, P; Lu, WJ; Mills, K; Daish, T; Kumar, S; (2004) The apical caspase dronc governs programmed and unprogrammed cell death in Drosophila. Dev Cell , 7 (6) pp. 897-907. 10.1016/j.devcel.2004.09.016.

Chow, E; Thirlwell, C; Macrae, F; Lipton, L; (2004) Colorectal cancer and inherited mutations in base-excision repair. LANCET ONCOL , 5 (10) 600 - 606.

Chowdhury, S; Chester, KA; Bridgewater, J; Collins, MK; Martin, F; (2004) Efficient retroviral vector targeting of carcinoembryonic antigen-positive tumors. MOL THER , 9 (1) 85 - 92. 10.1016/j.ymthe.2003.10.004.

Clamp, A; Adams, M; Atkinson, R; Boven, E; Calvert, AH; Cervantes, A; Ganesan, T; (2004) A phase IIA study of the topoisomerase I inhibitor, exatecan mesylate (DX-895 1f), administered at two different dose schedules in patients with platinum- and taxane-resistant/refractory ovarian cancer. GYNECOL ONCOL , 95 (1) 114 - 119. 10.1016/j.ygyno.2004.06.047.

Clark, FJ; Gregg, R; Piper, K; Dunnion, D; Freeman, L; Griffiths, M; Begum, G; (2004) Chronic graft-versus-host disease is associated with increased numbers of peripheral blood CD4(+)CD25(high) regulatory T cells. BLOOD , 103 (6) 2410 - 2416. 10.1182/blood-2003-06-2073.

Conde, L; Vaquerizas, JM; Santoyo, J; Al-Shahrour, F; Ruiz-Llorente, S; Robledo, M; Dopazo, J; (2004) PupaSNP Finder: a web tool for finding SNPs with putative effect at transcriptional level. Nucleic Acids Res , 32 (Web Serv) W242-W248. 10.1093/nar/gkh438.

Craig, CEH; Quaglia, A; Dhillon, AP; (2004) Extramedullary haematopoiesis in massive hepatic necrosis. HISTOPATHOLOGY , 45 (5) 518 - 525.

Craig, CEH; Quaglia, A; Dhillon, AP; (2004) Massive hepatic necrosis and extramedullary haemopoiesis. In: JOURNAL OF HEPATOLOGY. (pp. 42 - 42). ELSEVIER SCIENCE BV

Craig, CEH; Quaglia, A; Selden, C; Lowdell, M; Hodgson, H; Dhillon, AP; (2004) The histopathology of regeneration in massive hepatic necrosis. SEMIN LIVER DIS , 24 (1) 49 - 64.

Curtin, NJ; Barlow, HC; Bowman, KJ; Calvert, AH; Davison, R; Golding, BT; Huang, B; (2004) Resistance-modifying agents. 11. Pyrimido[5,4-d]pyrimidine modulators of antitumor drug activity. Synthesis and structure-activity relationships for nucleoside transport inhibition and binding to alpha(1)-acid glycoprotein. J MED CHEM , 47 (20) 4905 - 4922. 10.1021/jm040772w.

D

D'Sa, S; Yong, K; Kyriakou, C; Bhattacharya, S; Peggs, KS; Foulkes, B; Watts, MJ; (2004) Etoposide, methylprednisolone, cytarabine and cisplatin successfully cytoreduces resistant myeloma patients and mobilizes them for transplant without adverse effects. British Journal of Haematology , 125 (6) pp. 756-765. 10.1111/j.1365-2141.2004.04981.x.

D'Sa, S; Yong, K; Kyriakou, C; Bhattacharya, S; Peggs, KS; Foulkes, B; Watts, MJ; (2004) Etoposide, methylprednisolone, cytarabine and cisplatin successfully cytoreduces resistant myeloma patients and mobilizes them for transplant without adverse effects. BRIT J HAEMATOL , 125 (6) 756 - 765. 10.1111/j.1365-2141.2004.04981.x.

Danovi, D; Meulmeester, E; Pasini, D; Migliorini, D; Capra, M; Frenk, R; de Graaf, P; (2004) Amplification of Mdmx (or Mdm4) directly contributes to tumor formation by inhibiting p53 tumor suppressor activity. MOL CELL BIOL , 24 (13) 5835 - 5843. 10.1128/MCB.24.13.5835-5843.2004.

Davidoff, AM; Nathwani, AC; (2004) Antiangiogenic gene therapy for cancer treatment. Curr Hematol Rep , 3 (4) pp. 267-273.

Davidoff, AM; Ng, CYC; Sleep, S; Gray, J; Azam, S; Zhao, Y; McIntosh, JH; (2004) Purification of recombinant adeno-associated virus type 8 vectors by ion exchange chromatography generates clinical grade vector stock. J VIROL METHODS , 121 (2) 209 - 215. 10.1016/j.jviromet.2004.07.001.

Davies, JK; Koh, MBC; Lowdell, MW; (2004) Antiviral immunity and T-regulatory cell function are retained after selective alloreactive T-cell depletion in both the HLA-identical and HLA-mismatched settings. BIOL BLOOD MARROW TR , 10 (4) 259 - 268. 10.1016/j.bbmt.2003.12.001.

Davis, BA; O'Sullivan, C; Jarritt, PH; Porter, JB; (2004) Value of sequential monitoring of left ventricular ejection fraction in the management of thalassemia major. BLOOD , 104 (1) 263 - 269. 10.1182/blood-2003-08-2841.

Dearling, J.L.J.; Flynn, A.A.; Sutcliffe-Goulden, J.; Petrie, I.A.; Boden, R.; Green, A.J.; Boxer, G.M.; (2004) Analysis of the regional uptake of radiolabeled deoxyglucose analogs in human tumor xenografts. The Journal of Nuclear Medicine , 45 (1) pp. 101-107.

Dearling, JLJ; Flynn, AA; Sutcliffe-Goulden, J; Petrie, IA; Boden, R; Green, AJ; Boxer, GM; (2004) Analysis of the regional uptake of radiolabeled deoxyglucose analogs in human tumor xenografts. J NUCL MED , 45 (1) 101 - 107.

Delaunay, J; Nouyrigat, V; Proust, A; Schischmanoff, PO; Cynober, T; Yvart, J; Gaillard, C; (2004) Different impacts of alleles alphaLEPRA and alphaLELY as assessed versus a novel, virtually null allele of the SPTA1 gene in trans. Br J Haematol , 127 (1) pp. 118-122. 10.1111/j.1365-2141.2004.05160.x.

Deloukas, P; Earthrowl, ME; Grafham, DV; Rubenfield, M; French, L; Steward, CA; Sims, SK; (2004) The DNA sequence and comparative analysis of human chromosome 10. NATURE , 429 (6990) 375 - 381. 10.1038/nature02462.

Direkze, NC; Hodivala-Dilke, K; Jeffery, R; Hunt, T; Poulsom, R; Oukrif, D; Alison, MR; (2004) Bone marrow contribution to tumor-associated myofibroblasts and fibroblasts. CANCER RES , 64 (23) 8492 - 8495.

Duarte, RF; Delgado-Gonzalez, J; Quaglia, AF; Shaw, B; Wrench, D; Ethell, M; Dhillon, AP; (2004) Graft-versus-host disease of the liver: 109 cases from a single-centre. BONE MARROW TRANSPLANTATION , 33 S175 - S175.

Duarte, RF; Delgado-Gonzalez, J; Shaw, BE; Wrench, D; Ethell, M; Patch, D; Dhillon, AP; (2004) Pathologic features may predict the clinical outcome of hepatic graft versus host disease (H-GVHD). Blood , 104 (11) 5079-.

Duarte, RF; Delgado-Gonzalez, J; Shaw, BE; Wrench, D; Ethell, M; Patch, D; Dhillon, AP; (2004) Pathologic features may predict the clinical outcome of hepatic graft versus host disease (H-GVHD). In: BLOOD. (pp. 353B - 353B). AMER SOC HEMATOLOGY

Dunham, A; Matthews, LH; Burton, J; Ashurst, JL; Howe, KL; Ashcroft, KJ; Beare, DM; (2004) The DNA sequence and analysis of human chromosome 13. NATURE , 428 (6982) 522 - 528. 10.1038/nature02379.

Dunham, A.; Matthews, L.H.; Burton, J.; Ashurst, J.L.; Howe, K.L.; Ashcroft, K.J.; Beare, D.M.; (2004) The DNA sequence and analysis of human chromosome 13. Nature , 428 (6982) pp. 522-528. 10.1038/nature02379.

E

ELhamidi, A; Hamoudi, RA; Kocjan, G; Du, MQ; (2004) Cervical intraepithelial neoplasia: prognosis by combined LOH analysis of multiple loci. GYNECOL ONCOL , 94 (3) 671 - 679. 10.1016/j.ygyno.2004.06.013.

Eckhardt, F; Beck, S; Gut, IG; Berlin, K; (2004) Future potential of the human epigenome project. EXPERT REV MOL DIAGN , 4 (5) 609 - 618.

Ellis, IO; Bartlett, J; Dowsett, M; Humphreys, S; Jasani, B; Miller, K; Pinder, SE; (2004) Updated recommendations for HER2 testing in the UK. J CLIN PATHOL , 57 (3) 233 - 237. 10.1136/jcp.2003.007724.

Eward, KL; Obermann, EC; Shreeram, S; Loddo, M; Fanshawe, T; Williams, C; Jung, HI; (2004) DNA replication licensing in somatic and germ cells. J CELL SCI , 117 (24) 5875 - 5886. 10.1242/jcs.01503. Green open access
file

F

Feber, A; Clark, J; Goodwin, G; Dodson, AR; Smith, PH; Fletcher, A; Edwards, S; (2004) Amplification and overexpression of E2F3 in human bladder cancer. ONCOGENE , 23 (8) 1627 - 1630. 10.1038/sj.onc.1207274.

Feinberg, J; Fieschi, C; Doffinger, R; Feinberg, M; Leclerc, T; Boisson-Dupuis, S; Picard, C; (2004) Bacillus Calmette Guerin triggers the IL-12/IFN-gamma axis by an IRAK-4- and NEMO-dependent, non-cognate interaction between monocytes, NK, and T lymphocytes. Eur J Immunol , 34 (11) pp. 3276-3284. 10.1002/eji.200425221.

Feingold, EA; Good, PJ; Guyer, MS; Kamholz, S; Liefer, L; Wetterstrand, K; Collins, FS; (2004) The ENCODE (ENCyclopedia of DNA elements) Project. SCIENCE , 306 (5296) 636 - 640. 10.1126/science.1105136.

Flanagan, J; Healey, S; Young, J; Whitehall, V; Trott, D; Newbold, R; Chenevix-Trench, G; (2004) Mapping of a candidate colorectal cancer tumour suppressor gene to a 900 kilobase region on the short arm of chromosome 8. Genes, Chromosomes and Cancer , 40 (3) pp. 247-260.

Folarin, NI; Baker, RJ; Duke, V; Yogashangary, BC; Vadikolia, C; Wickremasinghe, RG; Casanova, AA; (2004) Zap-70 and 19V(H) mutation status in combination with p53 functional analysis identifies the response of poor prognosis B-CLL patients to conventional cytotoxic agents. In: BLOOD. (pp. 527A - 528A). AMER SOC HEMATOLOGY

Forshew, T; Johnson, CA; (2004) SCAMP: a spreadsheet to collate autozygosity mapping projects. J Med Genet , 41 (12) , Article e125. 10.1136/jmg.2004.023663.

Foster, CS; Falconer, A; Dodson, AR; Norman, AR; Dennis, N; Fletcher, A; Southgate, C; (2004) Transcription factor E2F3 overexpressed in prostate cancer independently predicts clinical outcome. ONCOGENE , 23 (35) 5871 - 5879. 10.1038/sj.onc.1207800.

Francis, RJ; Mather, SJ; Chester, K; Sharma, SK; Bhatia, J; Pedley, RB; Waibel, R; (2004) Radiolabelling of glycosylated MFE-23 :: CPG2 fusion protein (MFECP1) with Tc-99m for quantitation of tumour antibody-enzyme localisation in antibody-directed enzyme pro-drug therapy (ADEPT). EUR J NUCL MED MOL I , 31 (8) 1090 - 1096. 10.1007/s00259-004-1474-4.

Freeman, A; Geddes, N; Munson, P; Joseph, J; Ramani, P; Sandison, A; Fisher, C; (2004) Anaplastic lymphoma kinase (ALK1) staining and molecular analysis in inflammatory myofibroblastic tumours of the bladder: a preliminary clinicopathological study of nine cases and review of the literature. MODERN PATHOLOGY , 17 (7) pp. 765-771. 10.1038/modpathol.3800078.

Fricke, B; Jarvis, HG; Reid, CDL; Aguilar-Martinez, P; Robert, A; Quittet, P; Chetty, M; (2004) Four new cases of stomatin-deficient hereditary stomatocytosis syndrome: association of the stomatin-deficient cryohydrocytosis variant with neurological dysfunction. BRIT J HAEMATOL , 125 (6) 796 - 803. 10.1111/j.1365-2141.2004.04965.x.

Friedmann, B; Caplin, M; Hartley, JA; Hochhauser, D; (2004) Modulation of DNA repair in vitro after treatment with chemotherapeutic agents by the epidermal growth factor receptor inhibitor gefitinib (ZD1839). CLIN CANCER RES , 10 (19) 6476 - 6486.

G

Gandini, D; Allen, AJR; Nash, MJ; Linch, DC; Gale, RE; (2004) No mutations in the GATA-1 gene detected in patients with acquired essential thrombocythemia. HAEMATOLOGICA , 89 (5) 613 - 615. Gold open access

Garcia, CA; Robinson, J; Madrigal, AJ; Marsh, SGE; (2004) Killer cell immunoglobulin-like receptors (KIR). In: The EBMT handbook: Haemopoitic Stem Cell Transplantation. (pp. 48-55). European School of Haematology: Paris.

Garcia-Ortiz, JE; Cox, ST; Sandoval-Ramirez, L; Little, AM; Marsh, SGE; Madrigal, JA; Arguello, JR; (2004) A novel HLA-A allele: A*0257. TISSUE ANTIGENS , 63 (1) pp. 85-87. 10.1111/j.1399-0039.2004.00154.x.

Gerrard, G; Butters, TD; Mehta, AB; Hoffbrand, AV; Hughes, D; Burgess, M; Ganeshaguru, K; (2004) Glucosylceramide synthetase inhibitors sensitise B-CLL cells to cytotoxic agents without reversing P-gp functional activity. In: BLOOD. (pp. 334A - 334A). AMER SOC HEMATOLOGY

Gerrard, G; Mitchell, W; Goldstone, A; Chopra, R; Buck, G; Richards, S; Foroni, L; (2004) Sequential quantitative minimal residual disease in BCR-ABL positive acute lymphoblastic leukaemia: Differential observations between major and minor fusion gene rearrangements and variation due to source material. In: (Proceedings) 46th Annual Meeting of the American-Society-of-Hematology. (pp. 311A-311A). AMER SOC HEMATOLOGY

Gerrard, G; Payne, E; Baker, RJ; Jones, DT; Potter, M; Prentice, HG; Ethell, M; (2004) Clinical effects and P-glycoprotein inhibition in patients with acute myeloid leukemia treated with zosuquidar trihydrochloride, daunorubicin and cytarabine. Haematologica , 89 (7) pp. 782-790.

Gerrard, G; Payne, E; Baker, RJ; Jones, DT; Potter, M; Prentice, HG; Ethell, M; (2004) Clinical effects and P-glycoprotein inhibition in patients with acute myeloid leukemia treated with zosuquidar trihydrochloride, daunorubicin and cytarabine. HAEMATOLOGICA , 89 (7) pp. 782-790. Gold open access

Giampieri, S; Garcia-Escudero, R; Green, J; Storey, A; (2004) Human papillomavirus type 77 E6 protein selectively inhibits p53-dependent transcription of proapoptotic genes following UV-B irradiation. ONCOGENE , 23 (34) 5864 - 5870. 10.1038/sj.onc.1207711.

Giampieri, S; Storey, A; (2004) Repair of UV-induced thymine dimers is compromised in cells expressing the E6 protein from humanpapillomaviruses types 5 and 18. BRIT J CANCER , 90 (11) 2203 - 2209. 10.1038/sj.bjc.6601829.

Ginhoux, F; Turbant, S; Gross, DA; Poupiot, J; Marais, T; Lone, Y; Lemonnier, FA; (2004) HLA-A*0201-restricted cytolytic responses to the rtTA transactivator dominant and cryptic epitopes compromise transgene expression induced by the tetracycline on system. Mol Ther , 10 (2) pp. 279-289. 10.1016/j.ymthe.2004.05.012.

Gissen, P; Johnson, CA; Morgan, NV; Stapelbroek, JM; Forshew, T; Cooper, WN; McKiernan, PJ; (2004) Mutations in VPS33B, encoding a regulator of SNARE-dependent membrane fusion, cause arthrogryposis-renal dysfunction-cholestasis (ARC) syndrome. NAT GENET , 36 (4) 400 - 404. 10.1038/ng1325.

Godfrey, A; Anderson, J; Papanastasiou, A; Takeuchi, Y; Boshoff, C; (2004) Related ArInhibiting primary effusion lymphoma by lentiviral vectors encoding short hairpin RNA. Blood

Gomez, K; Laffan, MA; (2004) Hunting for the mutation in inherited thrombophilia. Blood Coagulation and Fibrinolysis , 15 (2) pp. 125-127.

Gomez, K; Laffan, MA; Kemball-Cook, G; Pasi, J; Layton, M; Singer, JD; Tuddenham, EG; (2004) Two novel mutations in severe factor VII deficiency. British Journal of Haematology , 126 (1) pp. 105-110.

Goyenvalle, A; Vulin, A; Fougerousse, F; Leturcq, F; Kaplan, JC; Garcia, L; Danos, O; (2004) Rescue of dystrophic muscle through U7 snRNA-mediated exon skipping. Science , 306 (5702) pp. 1796-1799. 10.1126/science.1104297.

Goyenvalle, A; Vulin, A; Fougerousse, F; Leturcq, F; Kaplan, JC; Garcia, L; Danos, O; (2004) [An opening in Duchenne muscular dystrophy: persistent therapeutic rescue of dystrophin by vectorized antisense mediated exon skipping in mdx mice]. Med Sci (Paris) , 20 (12) pp. 1163-1165. 10.1051/medsci/200420121163.

Graff, CP; Chester, K; Begent, R; Wittrup, KD; (2004) Directed evolution of an anti-carcinoembryonic antigen scFv with a 4-day monovalent dissociation half-time at 37 degrees C. PROTEIN ENG DES SEL , 17 (4) 293 - 304. 10.1093/protein/gzh038.

Grasso, A; Stigliano, R; Morisco, F; Quaglia, A; Dhillon, AP; Davidson, B; Rolles, K; (2004) Hepatocellular carcinoma treated by orthotopic liver transplantation: Prediction for recurrence. Journal of Hepatology , 40 130-.

Grasso, A; Stigliano, R; Morisco, F; Quaglia, A; Dhillon, AP; Davidson, B; Rolles, K; (2004) Hepatocellular carcinoma treated by orthotopic liver transplantation: Prediction for recurrence. Gut , 53 A119-A119.

Grasso, A; Stigliano, R; Morisco, F; Quaglia, A; Dhillon, AP; Davidson, B; Rolles, K; (2004) Hepatocellular carcinoma treated by orthotopic liver transplantation: Prediction for recurrence. In: JOURNAL OF HEPATOLOGY. (pp. 46 - 46). ELSEVIER SCIENCE BV

Green, A; Flynn, A; Pedley, RB; Dearling, J; Begent, R; (2004) Nonuniform absorbed dose distribution in the kidney: The influence of organ architecture. CANCER BIOTHER RADIO , 19 (3) 371 - 377.

Gregson, SJ; Howard, PW; Gullick, DR; Hamaguchi, A; Corcoran, KE; Brooks, NA; Hartley, JA; (2004) Linker length modulates DNA cross-linking reactivity and cytotoxic potency of C8/C8 ' ether-linked C2-exo-unsaturated pyrrolo[2,1-c][1,4]benzodiazepine (PBD) dimers. J MED CHEM , 47 (5) 1161 - 1174. 10.1021/jm0308971.

Grimwade, D; Enver, T; (2004) Acute promyelocytic leukemia: where does it stem from? LEUKEMIA , 18 (3) pp. 375-384. 10.1038/sj.leu.2403234.

H

Hague, A; Eveson, JW; MacFarlane, M; Huntley, S; Janghra, N; Thavaraj, S; (2004) Caspase-3 expression is reduced, in the absence of cleavage, in terminally differentiated normal oral epithelium but is increased in oral squamous cell carcinomas and correlates with tumour stage. JOURNAL OF PATHOLOGY , 204 (2) pp. 175-182. 10.1002/path.1630.

Hall-Craggs, MA; Porter, J; Gatehouse, PD; Bydder, GM; (2004) Ultrashort echo time (UTE) MRI of the spine in thalassaemia. BRIT J RADIOL , 77 (914) 104 - 110. 10.1259/bjr/53300812.

Hamoudi, R; Diss, TC; Oksenhendler, E; Pan, LX; Carbone, A; Ascoli, V; Boshoff, C; (2004) Distinct cellular origins of primary effusion lymphoma with and without EBV infection. LEUKEMIA RES , 28 (4) 333 - 338. 10.1016/j.leukres.2003.08.003.

Hampel, C.; (2004) Deregulation of E2f-1 and chemosensitivity. Doctoral thesis, University of London. Green open access
file

Hartley, J.A.; Spanswick, V.J.; Brooks, N.; Clingen, P.H.; McHugh, P.J.; Hochhauser, D.; Pedley, R.B.; (2004) SJG-136 (NSC 694501), a novel rationally designed DNA minor groove interstrand cross-linking agent with potent and broad spectrum antitumor activity. Cancer Research , 64 (18) pp. 6693-6699.

Hartley, JA; Spanswick, VJ; Brooks, N; Clingen, PH; McHugh, PJ; Hochhauser, D; Pedley, RB; (2004) SJG-136 (NSC 694501), a novel rationally designed DNA minor groove interstrand cross-linking agent with potent and broad spectrum antitumor activity. Part 1: Cellular pharmacology, in vitro and initial in vivo antitumor activity. CANCER RES , 64 (18) 6693 - 6699.

Hartley, JA; Spanswick, VJ; Brooks, N; Clingen, PH; McHugh, PJ; Hochhauser, D; Pedley, RB; (2004) SJG-136 (NSC 694501), a novel rationally designed DNA minor groove interstrand cross-linking agent with potent and broad spectrum antitumor activity: part 1: cellular pharmacology, in vitro and initial in vivo antitumor activity. Cancer Res , 64 (18) pp. 6693-6699. 10.1158/0008-5472.CAN-03-2941.

Haynes, SVZ; Dudderidge, TJ; (2004) Emergency contraception: the journey so far. BJOG-INT J OBSTET GY , 111 (1) 91 - 91. 10.1046/j.1471-5028.2003.00020.x.

Henry, JA; Le, NM; Nguyen, B; Howard, CM; Bailey, SL; Horick, SM; Buchmueller, KL; (2004) Targeting the inverted CCAAT box 2 in the topoisomerase II alpha promoter by JH-37, an imidazole-pyrrole polyamide hairpin: Design, synthesis, molecular biology, and biophysical studies. BIOCHEMISTRY-US , 43 (38) 12249 - 12257. 10.1021/bi048785z.

Herrero, J; Vaquerizas, JM; Al-Shahrour, F; Conde, L; Mateos, A; Diaz-Uriarte, JSR; Dopazo, J; (2004) New challenges in gene expression data analysis and the extended GEPAS. NUCLEIC ACIDS RESEARCH , 32 W485-W491. 10.1093/nar/gkh421.

Hewison, M; Zehnder, D; Chakraverty, R; Adams, JS; (2004) Vitamin D and barrier function: a novel role for extra-renal 1 alpha-hydroxylase. MOLECULAR AND CELLULAR ENDOCRINOLOGY , 215 (1-2) 31 - 38. 10.1016/j.mce.2003.11.017.

Hollyman, D.R.; (2004) Cellular targets of Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen. Doctoral thesis, University of London. Green open access
file

Horton, R; Wilming, L; Rand, V; Lovering, RC; Bruford, EA; Khodiyar, VK; Lush, MJ; (2004) Gene map of the extended human MHC. NAT REV GENET , 5 (12) 889 - 899. 10.1038/nrg1489.

Hughes, DA; Li, A; Keshav, S; Mehta, A; (2004) Hepcidin dysregulation in patients with type 1 Gaucher's disease. In: BLOOD. (pp. 42B - 43B). AMER SOC HEMATOLOGY

Hughes, DA; Stuart-Smith, SE; Bain, BJ; (2004) How should stainable iron in bone marrow films be assessed? J Clin Pathol , 57 (10) pp. 1038-1040. 10.1136/jcp.2003.015834.

Hughes, SE; (2004) The pathology of hypertrophic cardiomyopathy. Histopathology , 44 pp. 412-427.

Huhalov, A; Chester, KA; (2004) Engineered single chain antibody fragments for radioimmunotherapy. Q J Nucl Med Mol Imaging , 48 (4) pp. 279-288.

Humphray, SJ; Oliver, K; Hunt, AR; Plumb, RW; Loveland, JE; Howe, KL; Andrews, TD; (2004) DNA sequence and analysis of human chromosome 9. NATURE , 429 (6990) 369 - 374. 10.1038/nature02465.

I

Irshad, S; Pedley, RB; Anderson, J; Latchman, DS; Budhram-Mahadeo, V; (2004) The Brn-3b transcription factor regulates the growth, behavior, and invasiveness of human neuroblastoma cells in vitro and in vivo. J BIOL CHEM , 279 (20) 21617 - 21627. 10.1074/jbc.M312506200. Gold open access

Irshad, S.; Pedley, R.B.; Anderson, J.; Latchman, D.S.; Budhram-Mahadeo, V.; (2004) The Brn-3b transcription factor regulates the growth, behavior, and invasiveness of human neuroblastoma cells in vitro and in vivo. Journal of Biological Chemistry , 279 (20) pp. 21617-21627. 10.1074/jbc.M312506200. Gold open access

Irshad, S.; Pedley, R.B.; Anderson, J.; Latchman, D.S.; Budhram-Mahadeo, V.; (2004) The Brn-3b transcription factor regulates the growth, behavior, and invasiveness of human neuroblastoma cells in vitro and in vivo. Journal of Biological Chemistry , 279 (20) p. 21617. 10.1074/jbc.M312506200. Gold open access

Israeli, D; Benchaouir, R; Ziaei, S; Rameau, P; Gruszczynski, C; Peltekian, E; Danos, O; (2004) FGF6 mediated expansion of a resident subset of cells with SP phenotype in the C2C12 myogenic line. J Cell Physiol , 201 (3) pp. 409-419. 10.1002/jcp.20088.

J

Jakupovic, I; Grandage, VL; Linch, DC; Khwaja, A; (2004) Lack of effect of the human GM-CSF analog E21R on the survival of primary human acute myeloid leukemia cells. BLOOD , 103 (8) 3230 - 3232.

Jakupovic, I.; Grandage, V.L.; Linch, D.C.; Khwaja, A.; (2004) Lack of effect of the human GM-CSF analog E21R on the survival of primary human acute myeloid leukemia cells. Blood , 103 (8) pp. 3230-3232. 10.1182/blood-2003-06-1985. Green open access
file

Jennings, BH; Shah, S; Yamaguchi, Y; Seki, M; Phillips, RG; Handa, H; Ish-Horowicz, D; (2004) Locus-specific requirements for Spt5 in transcriptional activation and repression in Drosophila. Curr Biol , 14 (18) pp. 1680-1684. 10.1016/j.cub.2004.08.066.

Jennings, I; Mackie, I; Arnout, J; Preston, FE; UK Natl External Quality, ; (2004) Lupus anticoagulant testing using plasma spiked with monoclonal antibodies: performance in the UKNEQAS proficiency testing programme. J THROMB HAEMOST , 2 (12) 2178 - 2184.

Johnson, KS; Chicken, DW; Pickard, DCO; Lee, AC; Briggs, G; Falzon, M; Bigio, IJ; (2004) Elastic scattering spectroscopy for intraoperative determination of sentinel lymph node status in the breast. J BIOMED OPT , 9 (6) 1122 - 1128. 10.1117/1.1802191.

Jones, C; Mackay, A; Grigoriadis, A; Cossu, A; Reis-Filho, JS; Fulford, L; Dexter, T; (2004) Expression profiling of purified normal human luminal and myoepithelial breast cells: Identification of novel prognostic markers for breast cancer. CANCER RES , 64 (9) 3037 - 3045.

Jones, DT; Addison, E; North, JM; Lowdell, MW; Hoffbrand, AV; Mehta, AB; Ganeshaguru, K; (2004) Geldanamycin and herbimycin A induce apoptotic killing of B chronic lymphocytic leukemia cells and augment the cells' sensitivity to cytotoxic drugs. BLOOD , 103 (5) 1855 - 1861. 10.1182/blood-2003-05-1603.

Jones, DT; Addison, E; North, JM; Lowdell, MW; Hoffbrand, AV; Mehta, AB; Ganeshaguru, K; (2004) Geldanamycin and herbimycin A induce apoptotic killing of B chronic lymphocytic leukemia cells and augment the cells' sensitivity to cytotoxic drugs. Blood , 103 (5) pp. 1855-1861. 10.1182/blood-2003-05-1603. Green open access
file

K

Keeling, DM; Mackie, IJ; Moody, A; Watson, HG; Haemostasis Thrombosis Task Force, ; Brit Comm Standards Haematology, ; (2004) The diagnosis of deep vein thrombosis in symptomatic outpatients and the potential for clinical assessment and D-dimer assays to reduce the need for diagnostic imaging. BRIT J HAEMATOL , 124 (1) 15 - 25.

Kemp, Z; Thirlwell, C; Sieber, O; Silver, A; Tomlinson, I; (2004) An update on the genetics of colorectal cancer. HUM MOL GENET , 13 R177 - R185. 10.1093/hmg/ddh247.

Khakoo, SI; Thio, CL; Martin, MP; Brooks, CR; Gao, XJ; Astemborski, J; Cheng, J; (2004) HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection. SCIENCE , 305 (5685) 872 - 874.

Kim, JB; O'Hare, MJ; Stein, R; (2004) Models of breast cancer: is merging human and animal models the future? Breast Cancer Res , 6 (1) pp. 22-30. 10.1186/bcr645.

Kim, JB; Stein, R; O'Hare, MJ; (2004) Three-dimensional in vitro tissue culture models of breast cancer-- a review. Breast Cancer Res Treat , 85 (3) pp. 281-291. 10.1023/B:BREA.0000025418.88785.2b.

Kupchinsky, S; Centioni, S; Howard, T; Trzupek, J; Roller, S; Carnahan, V; Townes, H; (2004) A novel class of achiral seco-analogs of CC-1065 and the duocarmycins: design, synthesis, DNA binding, and anticancer properties. BIOORGAN MED CHEM , 12 (23) 6221 - 6236.

L

Lacy, ER; Nguyen, B; Le, M; Cox, KK; O'Hare, C; Hartley, JA; Lee, M; (2004) Energetic basis for selective recognition of T center dot G mismatched base pairs in DNA by imidazole-rich polyamides. NUCLEIC ACIDS RES , 32 (6) 2000 - 2007. 10.1093/nar/gkh515. Gold open access

Landreau, CAS; LePla, RC; Shipman, M; Slawin, AMZ; Hartley, JA; (2004) Delineating noncovalent interactions between the azinomycins and double-stranded DNA: Importance of the naphthalene substitution pattern on interstrand cross-linking efficiency. ORG LETT , 6 (20) 3505 - 3507. 10.1021/ol048653y.

Ledermann, JA; Wheeler, S; (2004) How should we manage patients with "platinum-sensitive" recurrent ovarian cancer? CANCER INVEST , 22 2 - 10. 10.1081/CNV-200030117.

Leonard, RC; Lind, M; Twelves, C; Coleman, R; van Belle, S; Wilson, C; Ledermann, J; (2004) Conventional adjuvant chemotherapy versus single-cycle, autograft-supported, high-dose, late-intensification chemotherapy in high-risk breast cancer patients: a randomized trial. J Natl Cancer Inst , 96 (14) pp. 1076-1083. 10.1093/jnci/djh188.

Liu, HX; Hamoudi, RA; Ye, HT; Ruskone-Fourmestraux, A; Dogan, A; Isaacson, PG; Du, MQ; (2004) t(11;18)(q21;q21) of mucosa-associated lymphoid tissue lymphoma results from illegitimate non-homologous end joining following double strand breaks. BRITISH JOURNAL OF HAEMATOLOGY , 125 (3) pp. 318-329. 10.1111/j.1365-2141.2004.04909.x.

Lowe, GDO; Rumley, A; Mackie, IJ; (2004) Plasma fibrinogen. ANN CLIN BIOCHEM , 41 430 - 440.

M

Maccioni, RB; Lavados, M; Maccioni, CB; Mendoza-Naranjo, A; (2004) Biological markers of Alzheimer's disease and mild cognitive impairment. Curr Alzheimer Res , 1 (4) pp. 307-314.

Mackie, IJ; Lawrie, AS; Greenfield, RS; Guinto, ER; Machin, SJ; (2004) A new lupus anticoagulant test based on dilute prothrombin time. In: THROMBOSIS RESEARCH. (pp. 673 - 674). PERGAMON-ELSEVIER SCIENCE LTD

Mackinnon, S; Thomson, K; Morris, E; Kottaridis, PD; Peggs, KS; (2004) Reduced intensity transplantation: where are we now? HEMATOLOGY JOURNAL , 5 S34 - S38. 10.1038/sj.thj.6200419.

Marafioti, T; Mancini, C; Ascani, S; Sabattini, E; Zinzani, PL; Pozzobon, M; Pulford, K; (2004) Leukocyte-specific phosphoprotein-1 and PU.1: two useful markers for distinguishing T-cell-rich B-cell lymphoma from lymphocyte-predominant Hodgkin's disease. Haematologica , 89 (8) pp. 957-964.

Marafioti, T; Pozzobon, M; Hansmann, ML; Delsol, G; Pileri, SA; Mason, DY; (2004) Expression of intracellular signaling molecules in classical and lymphocyte predominance Hodgkin disease. Blood , 103 (1) pp. 188-193. 10.1182/blood-2003-05-1487.

Marsh, SG; (2004) Nomenclature for factors of the HLA system, update April 2004. Hum Immunol , 65 (7) pp. 770-771.

Marsh, SG; (2004) Nomenclature for factors of the HLA system, update August 2004. Tissue Antigens , 64 (6) pp. 711-712. 10.1111/j.1399-0039.2004.00334.x.

Marsh, SG; (2004) Nomenclature for factors of the HLA system, update August 2004. Eur J Immunogenet , 31 (6) 279-. 10.1111/j.1365-2370.2004.00485.x.

Marsh, SG; (2004) Nomenclature for factors of the HLA system, update February 2004. Eur J Immunogenet , 31 (2) 101-. 10.1111/j.1365-2370.2004.00453.x.

Marsh, SG; (2004) Nomenclature for factors of the HLA system, update February 2004. Tissue Antigens , 64 (1) pp. 106-107. 10.1111/j.1399-0039.2004.00265.x.

Marsh, SG; (2004) Nomenclature for factors of the HLA system, update February 2004. Hum Immunol , 65 (7) 768-.

Marsh, SG; (2004) Nomenclature for factors of the HLA system, update January 2004. Eur J Immunogenet , 31 (2) 99-. 10.1111/j.1365-2370.2004.00451.x.

Marsh, SG; (2004) Nomenclature for factors of the HLA system, update January 2004. Tissue Antigens , 63 (6) pp. 619-620. 10.1111/j.0001-2815.2004.00254.x.

Marsh, SG; (2004) Nomenclature for factors of the HLA system, update January 2004. Hum Immunol , 65 (7) 767-. 10.1016/j.humimm.2004.05.005.

Marsh, SG; (2004) Nomenclature for factors of the HLA system, update July 2004. Hum Immunol , 65 (11) pp. 1411-1412. 10.1016/j.humimm.2004.09.013.

Marsh, SG; (2004) Nomenclature for factors of the HLA system, update June 2004. Hum Immunol , 65 (11) pp. 1409-1410. 10.1016/j.humimm.2004.09.012.

Marsh, SG; (2004) Nomenclature for factors of the HLA system, update March 2004. Eur J Immunogenet , 31 (2) 103-. 10.1111/j.1365-2370.2004.00454.x.

Marsh, SG; (2004) Nomenclature for factors of the HLA system, update March 2004. Tissue Antigens , 64 (1) pp. 108-109. 10.1111/j.1399-0039.2004.00266.x.

Marsh, SG; (2004) Nomenclature for factors of the HLA system, update March 2004. Hum Immunol , 65 (7) 769-.

Marsh, SG; (2004) Nomenclature for factors of the HLA system, update May 2004. Hum Immunol , 65 (12) pp. 1546-1547.

Marsh, SG; (2004) Nomenclature for factors of the HLA system, update September 2003. Hum Immunol , 65 (1) pp. 90-91.

Marsh, SG; (2004) Nomenclature for factors of the HLA system, update September 2003. Tissue Antigens , 63 (2) pp. 190-191.

Marsh, SG; (2004) Nomenclature for factors of the HLA system, update September 2004. Tissue Antigens , 64 (6) pp. 713-714. 10.1111/j.1399-0039.2004.00335.x.

Marsh, SG; (2004) Nomenclature for factors of the HLA system, update September 2004. Eur J Immunogenet , 31 (6) 281-. 10.1111/j.1365-2370.2004.00486.x.

Marsh, SG; WHO Nomenclature Committee for Factors of the HLA System, ; (2004) Nomenclature for factors of the HLA system, update April 2004. Eur J Immunogenet , 31 (4) pp. 195-196. 10.1111/j.1365-2370.2004.00468.x.

Marsh, SG; WHO Nomenclature Committee for Factors of the HLA System, ; (2004) Nomenclature for factors of the HLA system, update August 2003. Tissue Antigens , 63 (1) pp. 98-99.

Marsh, SG; WHO Nomenclature Committee for Factors of the HLA System, ; (2004) Nomenclature for factors of the HLA system, update December 2003. Tissue Antigens , 63 (5) pp. 505-506. 10.1111/j.1399-0039.2004.00213.x.

Marsh, SG; WHO Nomenclature Committee for Factors of the HLA System, ; (2004) Nomenclature for factors of the HLA system, update July 2003. Tissue Antigens , 63 (1) pp. 96-97.

Marsh, SG; WHO Nomenclature Committee for Factors of the HLA System, ; (2004) Nomenclature for factors of the HLA system, update June 2004. Eur J Immunogenet , 31 (4) pp. 199-200. 10.1111/j.1365-2370.2004.00472.x.

Marsh, SG; WHO Nomenclature Committee for Factors of the HLA System, ; (2004) Nomenclature for factors of the HLA system, update May 2004. Eur J Immunogenet , 31 (4) pp. 197-198. 10.1111/j.1365-2370.2004.00469.x.

Marsh, SG; WHO Nomenclature Committee for Factors of the HLA System, ; (2004) Nomenclature for factors of the HLA system, update November 2003. Tissue Antigens , 63 (5) pp. 503-504. 10.1111/j.0001-2815.2004.00212.x.

Marsh, SG; WHO Nomenclature Committee for Factors of the HLA System, ; (2004) Nomenclature for factors of the HLA system, update October 2003. Tissue Antigens , 63 (5) pp. 501-502. 10.1111/j.0001-2815.2004.00211.x.

Martin, HM; Moore, KP; Bosmans, E; Davies, S; Burroughs, AK; Dhillon, AP; Tosh, D; (2004) Xanthine oxidoreductase is present in bile ducts of normal and cirrhotic liver. FREE RADICAL BIO MED , 37 (8) 1214 - 1223. 10.1016/j.freeradbiomed.2004.06.045.

Martineau, Y; Le Bec, C; Monbrun, L; Allo, V; Chiu, IM; Danos, O; Moine, H; (2004) Internal ribosome entry site structural motifs conserved among mammalian fibroblast growth factor 1 alternatively spliced mRNAs. Mol Cell Biol , 24 (17) pp. 7622-7635. 10.1128/MCB.24.17.7622-7635.2004.

Martins, LM; Morrison, A; Klupsch, K; Fedele, V; Moisoi, N; Teismann, P; Abuin, A; (2004) Neuroprotective role of the reaper-related serine protease HtrA2/Omi revealed by targeted deletion in mice. MOL CELL BIOL , 24 (22) 9848 - 9862. 10.1128/MCB.24.22.9848-9862.2004.

Masir, N; Jones, M; Pozzobon, M; Marafioti, T; Volkova, OY; Mechetina, LV; Hansmann, ML; (2004) Expression pattern of FCRL (FREB, FcRX) in normal and neoplastic human B cells. Br J Haematol , 127 (3) pp. 335-343. 10.1111/j.1365-2141.2004.05193.x.

Mayer, A; Francis, R; Sharma, SK; Sully, C; Parker, S; Tolner, B; Griffin, N; (2004) A phase I/II trial of antibody directed enzyme prodrug therapy (ADEPT) with MFECP1 and ZD2767P. British Journal of Cancer , 91 S8-S8.

Mayer, A; Francis, R; Sharma, SK; Sully, C; Parker, S; Tolner, B; Griffin, N; (2004) A phase I/II trial of antibody directed enzyme prodrug therapy (ADEPT) with MFECP1 and ZD2767P. In: BRITISH JOURNAL OF CANCER. (pp. S8 - S8). NATURE PUBLISHING GROUP

Mayer, A; Sharma, SK; Tolner, B; Minton, NP; Purdy, D; Amlot, P; Tharakan, G; (2004) Modifying an immunogenic epitope on a therapeutic protein: a step towards an improved system for antibody-directed enzyme prodrug therapy (ADEPT). Br J Cancer , 90 (12) pp. 2402-2410. 10.1038/sj.bjc.6601888.

Mayer, A; Sharma, SK; Tolner, B; Minton, NP; Purdy, D; Amlot, P; Tharakan, G; (2004) Modifying an immunogenic epitope on a therapeutic protein: a step towards an improved system for antibody-directed enzyme prodrug therapy (ADEPT). BRIT J CANCER , 90 (12) 2402 - 2410. 10.1038/sj.bjc.6601888.

Mayor, NP; Cox, ST; McWhinnie, AJ; Arguello, JR; Shaw, BE; Little, A-M; Madrigal, JA; (2004) Sequence of a novel HLA-A*0301 intronic variant (A*03010103). TISSUE ANTIGENS , 65 pp. 107-109.

McCabe, DJH; Harrison, P; Mackie, IJ; Sidhu, PS; Purdy, G; Lawrie, AS; Watt, H; (2004) Platelet degranulation and monocyte-platelet complex formation are increased in the acute and convalescent phases after ischaemic stroke or transient ischaemic attack. BRIT J HAEMATOL , 125 (6) 777 - 787. 10.1111/j.1365-2141.2004.04983.x.

McCabe, DJH; Harrison, P; Sidhu, PS; Mackie, IJ; Purdy, G; Lawrie, AS; Watt, H; (2004) Leucocyte-platelet complex formation is increased in patients with acute symptomatic compared with asymptomatic severe carotid stenosis. In: JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY. (pp. 522 - 522). B M J PUBLISHING GROUP

McStay, MK; Khan, K; Savage, K; Stubbs, M; Dhillon, AP; Caplin, M; (2004) Neuroendocrine-like differentiation in hepatocellular and pancreatic cancers. In: GASTROENTEROLOGY. (pp. A494 - A494). W B SAUNDERS CO

McTiernan, A; Whelan, JS; (2004) A Phase II Study of Docetaxel for the Treatment of Recurrent Osteosarcoma. Sarcoma , 8 (2-3) pp. 71-76. 10.1080/13577140410001711764. Gold open access

Medzihradszky, KF; Spencer, DIR; Sharma, SK; Bhatia, J; Pedley, RB; Read, DA; Begent, RHJ; (2004) Glycoforms obtained by expression in Pichia pastoris improve cancer targeting potential of a recombinant antibody-enzyme fusion protein. GLYCOBIOLOGY , 14 (1) 27 - 37. 10.1093/glycob/cwh001.

Meja, KK; Catley, MC; Cambridge, LM; Barnes, PJ; Lum, H; Newton, R; Giembycz, MA; (2004) Adenovirus-mediated delivery and expression of a cAMP-dependent protein kinase inhibitor gene to BEAS-2B epithelial cells abolishes the anti-inflammatory effects of rolipram, salbutamol, and prostaglandin E2: a comparison with H-89. J Pharmacol Exp Ther , 309 (2) pp. 833-844. 10.1124/jpet.103.060020.

Miller, RF; Isaacson, PG; Hall-Craggs, M; Lucas, S; Gray, F; Scaravilli, F; An, SF; (2004) Cerebral CD8+ lymphocytosis in HIV-1 infected patients with immune restoration induced by HAART. ACTA NEUROPATHOL , 108 (1) 17 - 23. 10.1007/s00401-004-0852-0.

Moon, LD; Brenner, C; Ancliff, P; McHugh, K; de Bruyn, R; (2004) Non-Hodgkin's lymphoma presenting with uterine and renal enlargement in a young girl. Pediatric Radiology , 34 (3) pp. 277-279.

Moroncini, G; Kanu, N; Solforosi, L; Abalos, G; Telling, GC; Head, M; Ironside, J; (2004) Motif-grafted antibodies containing the replicative interface of cellular PrP are specific for PrPSc. P NATL ACAD SCI USA , 101 (28) 10404 - 10409. 10.1073/pnas.0403522101.

Morris, E; Thomson, K; Craddock, C; Mahendra, P; Milligan, D; Cook, G; Smith, GM; (2004) Outcomes after alemtuzumab-containing reduced-intensity allogeneic transplantation regimen for relapsed and refractory non-Hodgkin lymphoma. BLOOD , 104 (13) 3865 - 3871. 10.1182/blood-2004-03-1105.

Morris, E.; Thomson, K.; Craddock, C.; Mahendra, P.; Milligan, D.; Cook, G.; Smith, G.M.; (2004) Outcomes after alemtuzumab-containing reduced-intensity allogeneic transplantation regimen for relapsed and refractory non-Hodgkin lymphoma. Blood , 104 (13) pp. 3865-3871. 10.1182/blood-2004-03-1105. Green open access
file

Munker, R; Schmid, C; Madrigal, JA; Kolb, HJ; (2004) An update on graft-versus-host and graft-versus-leukemia reactions: a summary of the sixth International Symposium held in Schloss Ellmau, Germany, January 22-24, 2004. BONE MARROW TRANSPLANTATION , 34 (9) pp. 767-780.

Murch, SH; Anthony, A; Casson, DH; Malik, M; Berelowitz, M; Dhillon, AP; Thomson, MA; (2004) Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children (Retraction of vol 351, pg 637, 1998). LANCET , 363 (9411) 750 - 750.

Murch, SH; Anthony, A; Casson, DH; Malik, M; Berelowitz, M; Dhillon, AP; Thomson, MA; (2004) Retraction of an interpretation. Lancet , 363 (9411) 750-. 10.1016/S0140-6736(04)15715-2.

Murphy, RT; Mogensen, J; Shaw, A; Kubo, T; Hughes, S; McKenna, WJ; (2004) Novel mutation in cardiac troponin I in recessive idiopathic dilated cardiomyopathy. LANCET , 363 (9406) pp. 371-372. 10.1016/S0140-6736(04)15468-8.

N

Nacheva, E; Brazma, D; Grace, C; (2004) The genetic profile of CML-new revelations with matrix CGH. Presented at: UNSPECIFIED.

Narat, S; Folarin, NI; Baker, RJ; Duke, V; Yogashangary, BC; Jones, DT; Hart, SM; (2004) The role of multidrug resistance proteins and drug sensitivity in relation to poor prognosis identified by ZAP-70 expression and IgV(H) mutation status in B-CLL. In: BLOOD. (pp. 281B - 281B). AMER SOC HEMATOLOGY

Nash, MJ; Camilleri, RS; Kunka, S; Mackie, IJ; Machin, SJ; Cohen, H; (2004) The anticardiolipin assay is required for sensitive screening for antiphospholipid antibodies. JOURNAL OF THROMBOSIS AND HAEMOSTASIS , 2 (7) 1077 - 1081.

Nash, MJ; Cohen, H; (2004) Management of Jehovah's Witness patients with haematological problems. BLOOD REV , 18 (3) 211 - 217. 10.1016/S0268-960X(03)00065-1.

Nathwani, AC; Davidoff, AM; Tuddenham, EGD; (2004) Prospects for gene therapy of haemophilia. HAEMOPHILIA , 10 (4) 309 - 318. 10.1111/j.1365-2516.2004.00926.x.

Newsom-Davis, T; Bower, M; Wildfire, A; Thirlwell, C; Nelson, M; Gazzard, B; Stebbing, J; (2004) Resolution of AIDS-related Castleman's disease with anti-CD20 monoclonal antibodies is associated with declining IL-6 and TNF-alpha levels. LEUKEMIA LYMPHOMA , 45 (9) 1939 - 1941. 10.1080/10428190410001693533.

Nivsarkar, MS; Nathwani, A; Mosley, K; Davies, N; Gregory, LG; David, AL; Themis, M; (2004) Testosterone induced increase in transgene expression in vivo using Adenoviral Gene Delivery Vectors. Presented at: 1st Annual Conference of the British-Society-for-Gene-Therapy, Keble Coll, Oxford, ENGLAND.

Nnene, IO; Nieto, JJ; Crow, JC; Sundaresan, M; MacLean, AB; Perrett, CW; Hardiman, P; (2004) Cell cycle and apoptotic proteins in relation to ovarian epithelial morphology. GYNECOL ONCOL , 92 (1) 247 - 251. 10.1016/j.ygyno.2003.08.040.

O

Obermann, EC; Diss, TC; Hamoudi, RA; Munson, P; Wilkins, BS; Camozzi, MLP; Isaacson, PG; (2004) Loss of heterozygosity at chromosome 9p2 I is a frequent finding in enteropathy-type T-cell lymphoma. JOURNAL OF PATHOLOGY , 202 (2) pp. 252-262. 10.1002/path.1506.

Okkenhaug, K; Bilancio, A; Emery, JL; Vanhaesebroeck, B; (2004) Phosphoinositide 3-kinase in T cell activation and survival. BIOCHEMICAL SOCIETY TRANSACTIONS , 32 pp. 332-335. 10.1042/BST0320332.

Okorokov, AL; Orlova, EV; Kingsbury, SR; Bagneris, C; Gohlke, U; Williams, GH; Stoeber, K; (2004) Molecular structure of human geminin. NAT STRUCT MOL BIOL , 11 (10) 1021 - 1022. 10.1038/nsmb835.

P

Papazisis, KT; Habeshaw, T; Miles, DW; Herceptin-EAP Study Group, ; (2004) Safety and efficacy of the combination of trastuzumab with docetaxel for HER2-positive women with advanced breast cancer. A review of the existing clinical trials and results of the expanded access programme in the UK. Int J Clin Pract , 58 (6) pp. 581-586.

Parker, LL; Lacy, SM; Farrugia, LJ; Evans, C; Robins, DJ; O'Hare, CC; Hartley, JA; (2004) A novel design strategy for stable metal complexes of nitrogen mustards as bioreductive prodrugs. J MED CHEM , 47 (23) 5683 - 5689. 10.1021/jm0449866w.

Paston, SJ; Dodi, IA; Madrigal, JA; (2004) Progress made towards the development of a CMV peptide vaccine. HUM IMMUNOL , 65 (5) pp. 544-549.

Pedley, RB; Sharma, SK; Hawkins, RE; Chester, KA; (2004) Antibody-directed enzyme-prodrug therapy. In: UNSPECIFIED (pp. 491-514).

Peggs, K; (2004) Imatinib mesylate - gold standards and silver linings. CLIN EXP MED , 4 (1) 1 - 9. 10.1007/s10238-004-0032-5.

Peggs, K; Mackinnon, S; (2004) Graft-versus-myeloma: are durable responses a clinical reality following donor lymphocyte infusion? LEUKEMIA , 18 (9) 1541 - 1542. 10.1038/sj.leu.2403432.

Peggs, KS; (2004) Cytomegalovirus following stem cell transplantation: from pharmacologic to immunologic therapy. Expert Rev Anti Infect Ther , 2 (4) pp. 559-573.

Peggs, KS; (2004) Immune reconstitution following stem cell transplantation. LEUKEMIA LYMPHOMA , 45 (6) 1093 - 1101. 10.1080/10428190310001641260.

Peggs, KS; (2004) Role of MabCampath in allogeneic transplantation. Ann Hematol , 83 Sup S66-S68. 10.1007/s00277-004-0850-2.

Peggs, KS; Mackinnon, S; (2004) Augmentation of virus-specific immunity after hematopoietic stem cell transplantation by adoptive T-Cell therapy. HUM IMMUNOL , 65 (5) 550 - 557. 10.1016/j.humimm.2004.02.016.

Peggs, KS; Mackinnon, S; (2004) Cytomegalovirus: the role of CMV post-haematopoietic stem cell transplantation. INT J BIOCHEM CELL B , 36 (4) 695 - 701. 10.1016/j.biocel.2003.08.008.

Peggs, KS; Mackinnon, S; (2004) Immune reconstitution following haematopoietic stem cell transplantation. BRIT J HAEMATOL , 124 (4) 407 - 420. 10.1046/j.1365-2141.2003.04767.x.

Peggs, KS; Thomson, K; Hart, DP; Geary, J; Morris, EC; Yong, K; Goldstone, AH; (2004) Dose-escalated donor lymphocyte inftisions following reduced intensity transplantation: toxicity, chimerism, and disease responses. BLOOD , 103 (4) 1548 - 1556.

Peltenburg, LT; de Bruin, EC; Meersma, D; Wilting, S; Jürgensmeier, JM; Schrier, PI; (2004) c-Myc is able to sensitize human melanoma cells to diverse apoptotic triggers. Melanoma Res , 14 (1) pp. 3-12.

Pereira, JJ; Meyer, T; Docherty, SE; Reid, HH; Marshall, J; Thompson, EW; Rossjohn, J; (2004) Bimolecular interaction of insulin-like growth factor (IGF) binding protein-2 with alphavbeta3 negatively modulates IGF-I-mediated migration and tumor growth. Cancer Res , 64 (3) pp. 977-984.

Perez, N; Bigey, P; Scherman, D; Danos, O; Piechaczyk, M; Pelegrin, M; (2004) Regulatable systemic production of monoclonal antibodies by in vivo muscle electroporation. Genet Vaccines Ther , 2 (1) 2-. 10.1186/1479-0556-2-2. Gold open access

Pileri, SA; Sabattini, E; Agostinelli, C; Bodega, L; Rossi, M; Zinzani, PL; Marafioti, T; (2004) Histopathology of B-cell chronic lymphocytic leukemia. In: UNSPECIFIED (807-viii).

Porakishvili, N; Manoussaka, M; Kulikova, N; Walton, J; Nathwani, A; Jewell, AP; Stevenson, F; (2004) Activation and proliferation of B cell chronic lymphocytic leukaemia (B-CLL) cells through anti-CD180, Anti-CD40 and IL-4. In: BLOOD. (pp. 277B - 277B). AMER SOC HEMATOLOGY

Pors, K; Paniwnyk, Z; Ruparelia, KC; Teesdale-Spittle, PH; Hartley, JA; Kelland, LR; Patterson, LH; (2004) Synthesis and biological evaluation of novel chloroethylaminoanthraquinones with potent cytotoxic activity against cisplatin-resistant tumor. J MED CHEM , 47 (7) 1856 - 1859. 10.1021/jm031070u.

Pozzobon, M; Marafioti, T; Hansmann, ML; Natkunam, Y; Mason, DY; (2004) Intracellular signalling molecules as immunohistochemical markers of normal and neoplastic human leucocytes in routine biopsy samples. Br J Haematol , 124 (4) pp. 519-533.

Q

Quezada, SA; Jarvinen, LZ; Lind, EE; Noelle, RJ; (2004) CD40/CD154 interactions at the interface of tolerance and immunity. ANNU REV IMMUNOL , 22 307 - 328. 10.1146/annurev.immunol.22.012703.104533.

R

Rakyan, VK; Hildmann, T; Novik, KL; Lewin, J; Tost, J; Cox, AV; Andrews, TD; (2004) DNA methylation profiling of the human major histocompatibility complex: A pilot study for the Human Epigenome Project. PLOS BIOL , 2 (12) , Article e405. 10.1371/journal.pbio.0020405. Green open access
file

Raslova, H; Komura, E; Le Couédic, JP; Larbret, F; Debili, N; Feunteun, J; Danos, O; (2004) FLI1 monoallelic expression combined with its hemizygous loss underlies Paris-Trousseau/Jacobsen thrombopenia. J Clin Invest , 114 (1) pp. 77-84. 10.1172/JCI21197.

Ravichandran, D; Kocjan, G; Falzon, M; Ball, RY; Ralphs, DNL; (2004) Imprint cytology of the sentinel lymph node in the assessment of axillary node status in breast carcinoma. EJSO , 30 (3) 238 - 242. 10.1016/j.ejso.2003.11.005.

Reid, AG; Nacheva, EP; (2004) A potential role for PRDM12 in the pathogenesis of chronic myeloid leukaemia with derivative chromosome 9 deletion. In: LEUKEMIA. (pp. 178 - 180). NATURE PUBLISHING GROUP

Reif, K; Okkenhaug, K; Sasaki, T; Penninger, JM; Vanhaesebroeck, B; Cyster, JG; (2004) Cutting edge: differential roles for phosphoinositide 3-kinases, p110gamma and p110delta, in lymphocyte chemotaxis and homing. J Immunol , 173 (4) pp. 2236-2240.

Revell, PA; Damien, E; Zhang, XS; Evans, P; Howlett, CR; (2004) The effect of magnesium ions on bone bonding to hydroxyapatite coating on titanium alloy implants. BIOCERAMICS, VOL 16 , 254-2 pp. 447-450.

Roberts, CH; Robinson, J; Dodi, IA; Madrigal, JA; Marsh, SGE; (2004) The European searchable tumour cell line database (ESTDAB). Genes and Immunity , 5 44-.

Roberts, I; Foster, N; Nacheva, E; Coleman, N; (2004) Paint-assisted microdissection-FISH: Rapid and simple mapping of translocation breakpoints in the embryonal rhabdomyosarcoma cell line RD. CYTOMETRY PART A , 58A (2) pp. 177-184. 10.1002/cyto.a.20025.

Rodriguez-Viciana, P; Sabatier, C; McCormick, F; (2004) Signaling specificity by Ras family GTPases is determined by the full spectrum of effectors they regulate. MOL CELL BIOL , 24 (11) 4943 - 4954. 10.1128/MCB.24.11.4943-4954.2004.

Rodríguez-Perales, S; Meléndez, B; Gribble, SM; Valle, L; Carter, NP; Santamaría, I; Conde, L; (2004) Cloning of a new familial t(3;8) translocation associated with conventional renal cell carcinoma reveals a 5 kb microdeletion and no gene involved in the rearrangement. Hum Mol Genet , 13 (9) pp. 983-990. 10.1093/hmg/ddh111.

Rusakiewicz, S; Dodi, IA; Loconto, J; Travers, PJ; Madrigal, JA; (2004) Can BCR/ABL breakpoint fusion peptides be used as a target for GVL immunotherapy by expanding peptide specific T cells in patients in vivo? Blood Cells, Molecules, and Diseases , 33 (3) p. 191.

S

Sainsbury, R; Shetty, A; Loddo, M; Stoeber, K; Williams, G; (2004) DNA replication licensing proteins and breast cancer - a novel class of prognostic markers? In: BREAST CANCER RESEARCH AND TREATMENT. (pp. S23 - S23). SPRINGER

Salomoni, P; Cossarizza, A; (2004) HIV: no PUMA no death? CELL DEATH DIFFER , 11 (7) 691 - 692. 10.1038/sj.cdd.4401446.

Samonakis, DN; Thalheimer, U; Quaglia, A; Mela, M; Triantos, CK; Dhillon, AP; Leandro, G; (2004) Prospective evaluation of hepatic venous pressure and evolution of recurrent HCV after liver transplantation. HEPATOLOGY , 40 (4) 362A - 362A.

Samonakis, DN; Triantos, CK; Thalheimer, U; Quaglia, A; Leandro, G; Papatheodoridis, GV; Teixeria, R; (2004) Donor age does not influence progression of HCV recurrence after liver transplantation. Journal of Hepatology , 40 14-.

Samonakis, DN; Triantos, CK; Thalheimer, U; Quaglia, A; Leandro, G; Papatheodoridis, GV; Teixeria, R; (2004) Donor age does not influence progression of HCV recurrence after liver transplantation. JOURNAL OF HEPATOLOGY , 40 6 - 7.

Sartor, O; Reid, RH; Hoskin, PJ; Quick, DP; Ell, PJ; Coleman, RE; Kotler, JA; (2004) Samarium-153-lexidronam complex for treatment of painful bone metastases in hormone-refractory prostate cancer. UROLOGY , 63 (5) 940 - 945. 10.1016/j.urology.2004.01.034.

Saunders, MI; Rojas, AM; (2004) Management of cancer of the head and neck--a cocktail with your PORT? N Engl J Med , 350 (19) pp. 1997-1999. 10.1056/NEJMe048038.

Sharp, T; Munoz, F; Bourboulia, D; Presneau, N; Darai, E; Wang, HW; Cannon, M; (2004) LIMD1, a tumor suppressor at 3p21.3, binds pRb and represses E2F-driven transcription. Proceedings of the National Academy of Sciences of the United States of America , 10 pp. 16531-16536. 10.1073/pnas.0407123101.

Sharp, TV; Munoz, F; Bourboulia, D; Presneau, N; Darai, E; Wang, HW; Cannon, M; (2004) LIM domains-containing protein 1 (LIMD1), a tumor suppressor encoded at chromosome 3p21.3, binds pRB and represses E2F-driven transcription. Proceedings of the National Academy of Sciences of the United States of America , 101 (47) pp. 16531-16536. 10.1073/pnas.0407123101.

Sharp, TV; Munoz, F; Bourboulia, D; Presneau, N; Darai, E; Wang, HW; Cannon, M; (2004) LIM domains-containing protein 1 (LIMD1), a tumor suppressor encoded at chromosome 3p2l.3, binds pRB and represses E2F-driven transcription. P NATL ACAD SCI USA , 101 (47) 16531 - 16536. 10.1073/pnas.0407123101.

Shaw, BE; Barber, LD; Madrigal, JA; Cleaver, S; Marsh, SGE; (2004) Scoring for HLA matching? A clinical test of HistoCheck. BONE MARROW TRANSPLANTATION , 34 (4) pp. 367-368.

Shaw, BE; Barber, LD; Madrigal, JA; Cleaver, S; Marsh, SGE; (2004) Scoring for HLA matching? A clinical test of HistoCheck. BONE MARROW TRANSPL , 34 (4) 367 - 368. 10.1038/sj.bmt.1704586.

Shaw, BE; Barber, LD; Madrigal, JA; Cleaver, S; Marsh, SGE; Elsner, HA; Blasczyk, R; (2004) Scoring for HLA matching? A clinical test of HistoCheck (multiple letters) [1]. Bone Marrow Transplantation , 34 (4) pp. 367-369. 10.1038/sj.bmt.1704586.

Shaw, BE; Maldonado, H; Madrigal, JA; Smith, C; Petronzelli, F; Mayor, NP; Potter, MN; (2004) Polymorphisms in the TNFA gene promoter region show evidence of strong linkage disequilibrium with HLA and are associated with delayed neutrophil engraftment in unrelated donor hematopoietic stem cell transplantation. Tissue Antigens , 63 (5) pp. 401-411. 10.1111/j.0001-2815.2004.00218.x.

Shaw, BE; Maldonaldo, H; Madrigal, JA; Smith, C; Petronzelli, F; Mayor, NP; Potter, MN; (2004) Polymorphisms in the TNFA gene promoter region show evidence of strong linkage disequilibrium with HLA and are associated with delayed neutrophil engraftment in unrelated donor hematopoietic stem cell transplantation. TISSUE ANTIGENS , 63 (5) 401 - 411.

Shetty, A; Sainsbury, R; Loddo, M; Stoeber, K; London, WG; (2004) DNA replication licensing proteins predict response to hormonal treatment in breast cancer. In: BREAST CANCER RESEARCH AND TREATMENT. (pp. S233 - S234). SPRINGER

Shiina, T; Shimizu, S; Hosomichi, K; Kohara, S; Watanabe, S; Hanzawa, K; Beck, S; (2004) Comparative genomic analysis of two avian (quail and chicken) MHC regions. J IMMUNOL , 172 (11) 6751 - 6763.

Sidwell, RU; Dhillon, AP; Butler, PEM; Rustin, MHA; (2004) Localized granulomatous reaction to a semi-permanent hyaluronic acid and acrylic hydrogel cosmetic filler. CLIN EXP DERMATOL , 29 (6) 630 - 632.

Sieben, NLG; Macropoulos, P; Roemen, GM; Kolkman-Uljee, SM; Fleuren, GJ; Houmadi, R; Diss, T; (2004) In ovarian neoplasms, BRAF, but not KRAS, mutations are restricted to low-grade serous tumours. J PATHOL , 202 (3) 336 - 340. 10.1002/path.1521.

Sieber, OM; Howarth, KM; Thirlwell, C; Rowan, A; Mandir, N; Goodlad, RA; Gilkar, A; (2004) Myh deficiency enhances intestinal tumorigenesis in multiple intestinal neoplasia (Apc(Min/+)) mice. CANCER RES , 64 (24) 8876 - 8881.

Sinclair, PB; Sorour, A; Martineau, M; Harrison, CJ; Mitchell, WA; O'Neill, E; Foroni, L; (2004) A fluorescence in situ hybridization map of 6q deletions in acute lymphocytic leukemia: Identification and analysis of a candidate tumor suppressor gene. CANCER RESEARCH , 64 (12) pp. 4089-4098. 10.1158/0008-5472.CAN-03-1871.

Steele, AJ; Casanova, AA; Hoffbrand, AV; Mehta, AB; Ganeshaguru, K; Jones, DT; Wickremasinghe, RG; (2004) The sesquiterpene lactone parthenolide rapidly and selectively induces apoptosis of B-chronic lymphocytic leukemia cells. In: BLOOD. (pp. 949A - 950A). AMER SOC HEMATOLOGY

Stegert, MR; Tamaskovic, R; Bichsel, SJ; Hergovich, A; Hemmings, BA; (2004) Regulation of NDR2 protein kinase by multi-site phosphorylation and the S100B calcium-binding protein. J BIOL CHEM , 279 (22) 23806 - 23812. 10.1074/jbc.M402472200. Gold open access

Stephens, P; Hunter, C; Bignell, G; Edkins, S; Davies, H; Teague, J; Stevens, C; (2004) Intragenic ERBB2 kinase mutations in tumours. NATURE , 431 (7008) 525 - 526. 10.1038/431525b.

Stewart, CA; Horton, R; Allcock, RJN; Ashurst, JL; Atrazhev, AM; Coggill, P; Dunham, I; (2004) Complete MHC haplotype disease gene mapping. GENOME RES , 14 (6) 1176 - 1187. 10.1101/gr.2188104.

Strauss, SJ; McTiernan, A; Whelan, JS; (2004) Late relapse of osteosarcoma: Implications for follow-up and screening. PEDIATR BLOOD CANCER , 43 (6) 692 - 697. 10.1002/pbc.20154.

Streck, CJ; Zhang, Y; Miyamoto, R; Zhou, J; Ng, CYC; Nathwani, AC; Davidoff, AM; (2004) Restriction of neuroblastoma angiogenesis and growth by interferon-alpha/beta. In: SURGERY. (pp. 183 - 189). MOSBY, INC

Streck, CJ; Zhou, JF; Ng, CY; Zhang, YB; Nathwani, AC; Davidoff, AM; (2004) Longterm recombinant adeno-associated, virus-mediated, liver-generated expression of an angiogenesis inhibitor improves survival in mice with disseminated neuroblastoma. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS , 199 (1) 78 - 86.

Stubbs, M; Khan, K; Watson, SA; Grimes, S; Michaeli, D; Savage, K; McStay, M; (2004) Specific targeting of CCK-2 receptor on gastric cancer cells with pentagastrin analogues. In: GUT. (pp. A118 - A118). B M J PUBLISHING GROUP

Sullivan, A; Syed, N; Gasco, M; Bergamaschi, D; Trigiante, G; Attard, M; Hiller, L; (2004) Polymorphism in wild-type p53 modulates response to chemotherapy in vitro and in vivo. Oncogene , 23 (19) pp. 3328-3337. 10.1038/sj.onc.1207428.

Swanton, C; (2004) Cell-cycle targeted therapies. Lancet Oncol , 5 (1) pp. 27-36.

Swanton, C; Johnston, S; (2004) New Targets and Innovative Strategies in Cancer Treatment: one year of progress. 13-14 February 2004, Nice, France. IDrugs , 7 (4) pp. 306-311.

Swanton, C; Nicke, B; Downward, J; (2004) RNA interference, DNA methylation, and gene silencing: a bright future for cancer therapy? Lancet Oncol , 5 (11) pp. 653-654. 10.1016/S1470-2045(04)01604-3.

T

Taher, A; Aoun, E; Sharara, AI; Mourad, F; Gharzuddine, W; Koussa, S; Inati, A; (2004) Five-year trial of deferiprone chelation therapy in thalassaemia major patients. ACTA HAEMATOL-BASEL , 112 (4) 179 - 183. 10.1159/000081268.

Takamiya, K; Kostourou, V; Adams, S; Jadeja, S; Chalepakis, G; Scambler, PJ; Huganir, RL; (2004) A direct functional link between the multi-PDZ domain protein GRIP1 and the Fraser syndrome protein Fras1. NAT GENET , 36 (2) 172 - 177. 10.1038/ng1292.

Tanriverdi, F; Gonzalez-Martinez, D; Silveira, LFG; Hu, Y; Maccoll, GS; Travers, P; Bouloux, PMG; (2004) Expression of gonadotropin-releasing hormone type-I (GnRH-I) and type-II (GnRH-II) in human peripheral blood mononuclear cells (PMBCs) and regulation of B-lymphoblastoid cell proliferation by GnRH-I and GnRH-II. EXP CLIN ENDOCR DIAB , 112 (10) 587 - 594. 10.1055/s-2004-830404.

Thomas, RM; Schmedt, C; Novelli, M; Choi, BK; Skok, J; Tarakhovsky, A; Roes, J; (2004) C-terminal Src kinase controls acute inflammation and granulocyte adhesion. IMMUNITY , 20 (2) 181 - 191.

Thomson, KJ; Ings, S; Watts, M; Mackinnon, S; Peggs, KS; (2004) CD34(+) cell dose and the occurrence of GVHD in the presence of in vivo T-cell depletion. BLOOD , 103 (2) 743 - 743.

Tikhe, JG; Webber, SE; Hostomsky, Z; Maegley, KA; Ekkers, A; Li, JK; Yu, XH; (2004) Design, synthesis, and evaluation of 3,4-dihydro-2H-[1,4]diazepino[6,7,1-hi]indol-1-ones as inhibitors of poly(ADP-ribose) polymerase. J MED CHEM , 47 (22) 5467 - 5481. 10.1021/jm030513r.

Tipping, AJ; Baluch, S; Barnes, DJ; Veach, DR; Clarkson, BM; Bornmann, WG; Mahon, FX; (2004) Efficacy of dual-specific Bcr-Abl and Src-family kinase inhibitors in cells sensitive and resistant to imatinib mesylate. LEUKEMIA , 18 (8) 1352 - 1356. 10.1038/sj.leu.2403416.

Tipping, AJ; Melo, JV; (2004) Comparative gene expression profile of p185(Bcr-Abl) versus p210(Bcr-Abl) expressing cells. LEUKEMIA RES , 28 (3) 219 - 220. 10.1016/j.leukres.2003.07.004.

Tipping, AJ; Vulliamy, TJ; Morgan, NV; Dokal, I; (2004) Molecular diagnosis of Fanconi anemia and dyskeratosis congenita. Methods Mol Med , 91 pp. 3-17.

Tomita, K; Kibe, T; Kang, HY; Seo, YS; Uritani, M; Ushimaru, T; Ueno, M; (2004) Fission yeast Dna2 is required for generation of the telomeric single-strand overhang. Mol Cell Biol , 24 (21) pp. 9557-9567. 10.1128/MCB.24.21.9557-9567.2004.

Tomita, K; Uritani, M; Ushimaru, T; Yoshinaga, K; Ueno, M; (2004) Sequence-specific binding of the Schizosaccharomyces pombe His1 protein to fission yeast telomeric DNA. Chem Biodivers , 1 (9) pp. 1344-1353. 10.1002/cbdv.200490097.

Towatari, M; Ciro, M; Ottolenghi, S; Tsuzuki, S; Enver, T; (2004) Involvement of mitogen-activated protein kinase in the cytokineregulated phosphorylation of transcription factor GATA-1. HEMATOLOGY JOURNAL , 5 (3) pp. 262-272. 10.1038/sj.thj.6200345.

Tsuzuki, S; Kitajima, K; Nakano, T; Glasow, A; Zelent, A; Enver, T; (2004) Cross talk between retinoic acid signaling and transcription factor GATA-2. MOLECULAR AND CELLULAR BIOLOGY , 24 (15) pp. 6824-6836. 10.1128/mcb.24.15.6824-6836.2004.

Tsuzuki, S; Seto, M; Greaves, M; Enver, T; (2004) Modeling first-hit functions of the t(12;21) TEL-AML1 translocation in mice. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA , 101 (22) pp. 8443-8448. 10.1073/pnas.0402063101.

U

Ueno, M; Murase, T; Kibe, T; Ohashi, N; Tomita, K; Murakami, Y; Uritani, M; (2004) Fission yeast Arp6 is required for telomere silencing, but functions independently of Swi6. Nucleic Acids Res , 32 (2) pp. 736-741. 10.1093/nar/gkh234. Gold open access

Uramoto, H; Hackzell, A; Wetterskog, D; Ballági, A; Izumi, H; Funa, K; (2004) pRb, Myc and p53 are critically involved in SV40 large T antigen repression of PDGF beta-receptor transcription. J Cell Sci , 117 (Pt 17) pp. 3855-3865. 10.1242/jcs.01228.

Uramoto, H; Wetterskog, D; Hackzell, A; Matsumoto, Y; Funa, K; (2004) p73 competes with co-activators and recruits histone deacetylase to NF-Y in the repression of PDGF beta-receptor. J Cell Sci , 117 (Pt 22) pp. 5323-5331. 10.1242/jcs.01384.

Urbaniak, MD; Bingham, JP; Hartley, JA; Woolfson, DN; Caddick, S; (2004) Design and synthesis of a nitrogen mustard derivative stabilized by apo-neocarzinostatin. J MED CHEM , 47 (19) 4710 - 4715. 10.1021/jm040790d.

V

Vanhaesebroeck, B; Rohn, JL; Waterfield, MD; (2004) Gene targeting: Attention to detail. CELL , 118 (3) pp. 274-276. 10.1016/j.cell.2004.07.018.

Vassileva, V; Millar, A; Briollais, L; Chapman, W; Bapat, B; (2004) Apoptotic and growth regulatory genes as mutational targets in mismatch repair deficient endometrioid adenocarcinomas of young patients. ONCOLOGY REPORTS , 11 (4) pp. 931-937.

Vig, S; Chitolie, A; Sleight, S; Bevan, D; Dormandy, J; Thompson, MM; Halliday, A; (2004) Prevalence and risk of thrombophilia defects in vascular patients. EUR J VASC ENDOVASC , 28 (2) 124 - 131. 10.1016/j.ejvs.2004.03.027.

Vineis, P; Alavanja, M; Buffler, P; Fontham, E; Franceschi, S; Gao, YT; Gupta, PC; (2004) Tobacco and cancer: Recent epidemiological evidence. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE , 96 (2) pp. 99-106. 10.1093/jnci/djh014.

Vineis, P.; Alavanja, M.; Buffler, P.; Fontham, E.; Franceschi, S.; Gao, Y.T.; Gupta, P.C.; (2004) Tobacco and cancer: recent epidemiological evidence. CancerSpectrum Knowledge Environment , 96 (2) pp. 99-106. 10.1093/jnci/djh014.

Violet, JA; Francis, R; Buscombe, JR; Croasdale, J; Parker, S; Amlot, P; Green, AJ; (2004) A dose-escalation-study evaluating the toxicity and therapeutic efficacy of I-131 labelled chimeric antibody CHT-25 in patients with IL-2 expressing lymphomas. Preliminary results. BRITISH JOURNAL OF CANCER , 91 S59 - S59.

Virchis, A; Koh, M; Rankin, P; Mehta, A; Potter, M; Hoffbrand, AV; Prentice, HG; (2004) Fludarabine, cytosine arabinoside, granulocyte-colony stimulating factor with or without idarubicin in the treatment of high risk acute leukaemia or myelodysplastic syndromes. BRITISH JOURNAL OF HAEMATOLOGY , 124 (1) pp. 26-32. 10.1046/j.1365-2141.2003.04728.x.

Viviani, B; Bartesaghi, S; Corsini, E; Galli, CL; Marinovich, M; (2004) Cytokines role in neurodegenerative events. TOXICOLOGY LETTERS , 149 (1-3) 85 - 89. 10.1016/j.toxlet.2003.12.022.

van Zuylen, L; Bridgewater, J; Sparreboom, A; Eskens, FALM; de Bruijn, P; Sklenar, I; Planting, AST; (2004) Phase I and pharmacokinetic study of the polyamine synthesis inhibitor SAM486A in combination with 5-fluorouracil/leucovorin in metastatic colorectal cancer. CLIN CANCER RES , 10 (6) 1949 - 1955.

W

Waddington, SN; Nivsarkar, MS; Mistry, AR; Buckley, SMK; Kemball-Cook, G; Mosley, KL; Mitrophanous, K; (2004) Permanent phenotypic correction of hemophilia B in immunocompetent mice by prenatal gene therapy. BLOOD , 104 (9) 2714 - 2721. 10.1182/blood-2004-02-0627.

Wald, NJ; Rodeck, C; Hackshaw, AK; Rudnicka, A; (2004) SURUSS in perspective. BJOG-INT J OBSTET GY , 111 (6) 521 - 531. 10.1111/j.1471-0528.2004.00193.x.

Wang, HW; Trotter, MWB; Lagos, D; Bourboulia, D; Henderson, S; Makinen, T; Elliman, S; (2004) Kaposi sarcoma herpesvirus-induced cellular reprogramming contributes to the lymphatic endothelial gene expression in Kaposi sarcoma. NAT GENET , 36 (7) 687 - 693. 10.1038/ng1384.

Watson, M; Foster, C; Eeles, R; Eccles, D; Ashley, S; Davidson, R; Mackay, J; (2004) Psychosocial impact of breast/ovarian (BRCA1/2) cancer-predictive genetic testing in a UK multi-centre clinical cohort. Br J Cancer , 91 (10) pp. 1787-1794. 10.1038/sj.bjc.6602207.

Wetterskog, D; Undeland, I; (2004) Loss of redness (a*) as a tool to follow hemoglobin-mediated lipid oxidation in washed cod mince. J Agric Food Chem , 52 (24) pp. 7214-7221. 10.1021/jf0307907.

Wharton, SB; Hibberd, S; Eward, KL; Crimmins, D; Jellinek, DA; Levy, D; Stoeber, K; (2004) DNA replication licensing and cell cycle kinetics of oligodendroglial tumours. BRIT J CANCER , 91 (2) 262 - 269. 10.1038/sj.bjc.6601949.

Whelan, JS; McTiernan, A; Kakouri, E; Kilby, A; London Bone and Soft Tissue Tumour, ; (2004) Carboplatin-based chemotherapy for refractory and recurrent Ewing's tumours. PEDIATR BLOOD CANCER , 43 (3) 237 - 242. 10.1002/pbc.20107.

Williams, GH; Swinn, R; Prevost, AT; de Clive-Lowe, P; Halsall, I; Going, JJ; Hales, CN; (2004) Diagnosis of oesophageal cancer by detection of minichromosome maintenance 5 protein in gastric aspirates. BRIT J CANCER , 91 (4) 714 - 719. 10.1038/sj.bjc.6602028.

Wilson, C; Nikitenko, LL; Sargent, IL; Rees, MC; (2004) Adrenomedullin: multiple functions in human pregnancy. Angiogenesis , 7 (3) pp. 203-212. 10.1007/s10456-004-4183-5.

Y

Yaguchi, H; Ohkura, N; Takahashi, M; Nagamura, Y; Kitabayashi, I; Tsukada, T; (2004) Menin missense mutants associated with multiple endocrine neoplasia type 1 are rapidly degraded via the ubiquitin-proteasome pathway. Mol Cell Biol , 24 (15) pp. 6569-6580. 10.1128/MCB.24.15.6569-6580.2004.

Yarranton, H; Lawrie, AS; Mackie, IJ; Pinkoski, L; Corash, L; Machin, SJ; (2004) Amotosalen hydrochloride (S-59) and UVA light treatment of cryosupernatant has no clinically significant effect on haemostatic proteins and appears suitable for plasma exchange in thrombotic thrombocytopenic purpura. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 34 - 34). BLACKWELL PUBLISHING LTD

Yarranton, H; Lawrie, AS; Purdy, G; Mackie, IJ; Machin, SJ; (2004) Comparison of von Willebrand factor antigen, von Willebrand factor-cleaving protease and protein S in blood components used for treatment of thrombotic thrombocytopenic purpura. TRANSFUSION MED , 14 (1) 39 - 44.

Ye, HT; Chuang, SS; Dogan, A; Isaacson, PG; Du, MQ; (2004) t(1;14) and t(11;18) in the differential diagnosis of Waldenstrom's macroglobulinemia. MODERN PATHOLOGY , 17 (9) pp. 1150-1154. 10.1038/modpathol.3800164.

Yung, L; Cunningham, D; Hancock, B; Smith, P; Maclennan, K; Linch, D; McMillan, A; (2004) Fludarabine, adriamycin and dexamethasone (FAD) in newly diagnosed advanced follicular lymphoma: a phase II study by the British National Lymphoma Investigation (BNLI). Br J Cancer , 91 (4) pp. 695-698. 10.1038/sj.bjc.6602031.

Yung, L; Smith, P; Hancock, BW; Hoskin, P; Gilson, D; Vernon, C; Linch, DC; (2004) Long term outcome in adolescents with Hodgkin's lymphoma: Poor results using regimens designed for adults. LEUKEMIA LYMPHOMA , 45 (8) 1579 - 1585. 10.1080/1042819042000209404.

Z

Zal, B; Kaski, JC; Arno, G; Akiyu, JP; Xu, Q; Cole, D; Whelan, M; (2004) Heat-shock protein 60-reactive CD4+CD28null T cells in patients with acute coronary syndromes. Circulation , 109 (10) pp. 1230-1235. 10.1161/01.CIR.0000118476.29352.2A.

Zal, B; am, K; Juan, A; Gavin, A; Julius, X; Qingbo, C; Della, W; (2004) Heat-shock protein 60-reactive CD4+CD28null T cells in patients with acute coronary syndromes. CIRCULATION , 109 (10) pp. 1230-1235.

Zelent, A; Greaves, M; Enver, T; (2004) Role of the TEL-AML1 fusion gene in the molecular pathogenesis of childhood acute lymphoblastic leukaemia. ONCOGENE , 23 (24) pp. 4275-4283. 10.1038/sj.onc.1207672.

This list was generated on Sun Dec 4 06:31:33 2016 GMT.